82 related articles for article (PubMed ID: 33337824)
21. HPV 16 detection in cervical lesions, physical state of viral DNA and changes in p53 gene.
do Horto dos Santos Oliveira L; Rodrigues Ede V; de Salles Lopes AP; Fernandez Ade P; Cavalcanti SM
Sao Paulo Med J; 2003 Mar; 121(2):67-71. PubMed ID: 12870053
[TBL] [Abstract][Full Text] [Related]
22. Performance of p16/Ki67 immunostaining, HPV E6/E7 mRNA testing, and HPV DNA assay to detect high-grade cervical dysplasia in women with ASCUS.
Zhu Y; Ren C; Yang L; Zhang X; Liu L; Wang Z
BMC Cancer; 2019 Mar; 19(1):271. PubMed ID: 30917784
[TBL] [Abstract][Full Text] [Related]
23. [Molecular biologic study on the carcinogenesis of HPV in uterine cervical cancer and related lesions--analysis of HPV types 16, 18 E6/E7 gene mRNA].
Nagai N
Nihon Sanka Fujinka Gakkai Zasshi; 1990 Aug; 42(8):823-33. PubMed ID: 2172419
[TBL] [Abstract][Full Text] [Related]
24. Human papillomavirus oncogene mRNA testing for the detection of anal dysplasia in HIV-positive men who have sex with men.
Silling S; Kreuter A; Hellmich M; Swoboda J; Pfister H; Wieland U
J Clin Virol; 2012 Apr; 53(4):325-31. PubMed ID: 22261122
[TBL] [Abstract][Full Text] [Related]
25. Clinical performance of human papillomavirus E6, E7 mRNA flow cytometric assay compared to human papillomavirus DNA typing.
Kottaridi C; Tsiodras S; Spathis A; Chranioti A; Pappas A; Kassanos D; Panayiotides I; Karakitsos P
Anal Quant Cytol Histol; 2011 Dec; 33(6):305-10. PubMed ID: 22590807
[TBL] [Abstract][Full Text] [Related]
26. Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou tests using real-time polymerase chain reaction analysis.
Wang-Johanning F; Lu DW; Wang Y; Johnson MR; Johanning GL
Cancer; 2002 Apr; 94(8):2199-210. PubMed ID: 12001118
[TBL] [Abstract][Full Text] [Related]
27. Eight-type human papillomavirus E6/E7 oncoprotein detection as a novel and promising triage strategy for managing HPV-positive women.
Rezhake R; Hu SY; Zhao S; Xu XQ; Zhao XL; Zhang L; Wang Y; Zhang X; Pan QJ; Qiao YL; Zhao FH
Int J Cancer; 2019 Jan; 144(1):34-42. PubMed ID: 29943809
[TBL] [Abstract][Full Text] [Related]
28. Human papillomavirus E6/E7 mRNA testing as a predictive marker for cervical carcinoma.
Lie AK; Kristensen G
Expert Rev Mol Diagn; 2008 Jul; 8(4):405-15. PubMed ID: 18598223
[TBL] [Abstract][Full Text] [Related]
29. Comparison Between HPV DNA Testing and HPV E6/E7 MRNA Testing in Women with Squamous Cell Abnormalities of the Uterine Cervix.
Dabeski D; Duvlis S; Basheska N; Antovska V; Stojovski M; Trajanova M; Dimitrov G; Dabeski A; Gureva-Gjorgievska N
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2019 May; 40(1):51-58. PubMed ID: 31152639
[TBL] [Abstract][Full Text] [Related]
30. HPV genotype determination and E6/E7 mRNA detection for management of HPV positive women.
Bruno MT; Ferrara M; Fava V; Rapisarda A; Coco A
Virol J; 2018 Mar; 15(1):52. PubMed ID: 29587778
[TBL] [Abstract][Full Text] [Related]
31. HPV-16-related proteins as the serologic markers in cervical neoplasia.
Park JS; Park DC; Kim CJ; Ahn HK; Um SJ; Park SN; Kim SJ; Namkoong SE
Gynecol Oncol; 1998 Apr; 69(1):47-55. PubMed ID: 9570998
[TBL] [Abstract][Full Text] [Related]
32. [Investigation of E6/E7 mRNAs of high risk human papilloma virus types by a commercial automatized NASBA assay in cervical swabs].
Ardiç N; Oztürk O; Ergünay K; Sezer O
Mikrobiyol Bul; 2009 Jul; 43(3):463-9. PubMed ID: 19795622
[TBL] [Abstract][Full Text] [Related]
33. Preliminary study of the use of E6/E7mRNA detection in screening and triage management of HR-HPV infection during pregnancy.
Yang YM; Wang SJ; Wang FY; Chen R; Xiao Q; Kang N; Liao QP
Ann Transl Med; 2021 Sep; 9(18):1428. PubMed ID: 34733980
[TBL] [Abstract][Full Text] [Related]
34. Quantification of HPV-16 E6-E7 transcription in cervical intraepithelial neoplasia by reverse transcriptase polymerase chain reaction.
Hsu EM; McNicol PJ; Guijon FB; Paraskevas M
Int J Cancer; 1993 Sep; 55(3):397-401. PubMed ID: 7690739
[TBL] [Abstract][Full Text] [Related]
35. Type-dependent E6/E7 mRNA expression of single and multiple high-risk human papillomavirus infections in cervical neoplasia.
Andersson E; Kärrberg C; Rådberg T; Blomqvist L; Zetterqvist BM; Ryd W; Lindh M; Horal P
J Clin Virol; 2012 May; 54(1):61-5. PubMed ID: 22326759
[TBL] [Abstract][Full Text] [Related]
36. Sensitivity and specificity of HR HPV E6/E7 mRNA test in detecting cervical squamous intraepithelial lesion and cervical cancer.
Pruski D; Millert-Kalinska S; Lewek A; Kedzia W
Ginekol Pol; 2019; 90(2):66-71. PubMed ID: 30860271
[TBL] [Abstract][Full Text] [Related]
37. Clinical value of the ThinPrep cytologic test with E6/E7 mRNA detection for cervical cancer screening in disease diagnosis.
Zhang L; Qi R; Wang L; Jiang F; Pan S; Fu W; Su Z; Gui D
Diagn Cytopathol; 2022 Nov; 50(11):513-517. PubMed ID: 35912779
[TBL] [Abstract][Full Text] [Related]
38. Letter to "The application of PAX1 methylation detection and HPV E6/E7 mRNA detection in cervical cancer screening".
Domenici L
J Obstet Gynaecol Res; 2021 Sep; 47(9):3419-3420. PubMed ID: 34155727
[No Abstract] [Full Text] [Related]
39. High risk HPV DNA subtypes and E6/E7 mRNA expression in a cohort of colposcopy patients from Northern Italy with high-grade histologically verified cervical lesions.
Ca L; A C; E M; D P; S M; J DI; A Z; G G; G B
Am J Transl Res; 2012; 4(4):452-7. PubMed ID: 23145213
[TBL] [Abstract][Full Text] [Related]
40. Value of TCT combined with HPV and CA125 in early cervical cancer screening in a medical examination population.
Xiao M; Zhang Z; Yu X; Fan Y; Chen X
Cell Mol Biol (Noisy-le-grand); 2022 Sep; 68(9):160-164. PubMed ID: 36905257
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
